Loading clinical trials...
Loading clinical trials...
The overarching hypothesis of this proposal is that IL-5 acts on multiple sinus tissue cell types, including plasma cells and epithelial cells, to promote immune dysregulation, and that inhibition of ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Brigham and Women's Hospital
NCT06914908 · Chronic Rhinosinusitis With Nasal Polyps
NCT05246267 · Chronic Rhinosinusitis With Nasal Polyps
NCT07125586 · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
NCT07268313 · Nasal Polyps
NCT06892704 · Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP), Smell Loss
Brigham and Women's Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions